Perguntar
Consultar
Descobrir
Calcular
Cadastre-se
Cadastre-se
Entrar
Entrar
Descobrir
HER2+ node-positive breast cancer: adjuvant pertuzumab benefit may hinge on residual risk after neoadjuvant therapy - Notícias Vera Health